Editas Medicine
EDIT
#7772
Rank
NZ$0.79 B
Marketcap
NZ$5.18
Share price
2.29%
Change (1 day)
-28.15%
Change (1 year)

Earnings for Editas Medicine (EDIT)

Earnings in 2026 (TTM): -NZ$0.13 Billion

According to Editas Medicine 's latest financial reports the company's current earnings are NZ$47 Million. In 2025 the company made an earning of -NZ$0.28 Billion, an increase over its 2024 earnings that were of -NZ$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Editas Medicine from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.13 Billion-55.75%
2025 -NZ$0.28 Billion-31.93%
2024 -NZ$0.41 Billion33.62%
2023 -NZ$0.31 Billion-25.13%
2022 -NZ$0.41 Billion16.98%
2021 -NZ$0.35 Billion43.24%
2020 -NZ$0.25 Billion-4.41%
2019 -NZ$0.26 Billion24.39%
2018 -NZ$0.21 Billion-4.98%
2017 -NZ$0.22 Billion22.73%
2016 -NZ$0.18 Billion172.88%
2015 -NZ$63.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-NZ$4.44 Million-96.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-NZ$0.14 Billion 4.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-NZ$0.4 Billion 219.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-NZ$0.22 Billion 71.45% Jersey